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Tylosin phosphate is a macrolide commonly administered to cattle in North America for
the control of liver abscesses. This study investigated the effect of in-feed administration
of tylosin phosphate to cattle at subtherapeutic levels and its subsequent withdrawal
on macrolide resistance using enterococci as an indicator bacterium. Fecal samples
were collected from steers that received no antibiotics and steers administered tylosin
phosphate (11 ppm) in-feed for 197 days and withdrawn 28 days before slaughter.
Enterococcus species isolated from fecal samples were identified through sequencing
the groES-EL intergenic spacer region and subject to antimicrobial susceptibility testing,
identification of resistance determinants and pulsed-field gel electrophoresis profiling.
Tylosin increased (P < 0.05) the proportion of eryR and tylR enterococci within the
population. Just prior to its removal, the proportion of eryR and tylR resistant enterococci
began decreasing and continued to decrease after tylosin was withdrawn from the diet
until there was no difference (P > 0.05) between treatments on d 225. This suggests
that antibiotic withdrawal prior to slaughter contributes to a reduction in the proportion
of macrolide resistant enterococci entering the food chain. Among the 504 enterococci
isolates characterized, Enterococcus hiraewas found to predominate (n = 431), followed
by Enterococcus villorum (n = 32), Enterococcus faecium (n = 21), Enterococcus
durans (n = 7), Enterococcus casseliflavus (n = 4), Enterococcus mundtii (n = 4),
Enterococcus gallinarum (n = 3), Enterococcus faecalis (n = 1), and Enterococcus
thailandicus (n = 1). The diversity of enterococci was greater in steers at arrival than
at exit from the feedlot. Erythromycin resistant isolates harbored the erm(B) and/ormsrC
gene. Similar PFGE profiles of eryR E. hirae pre- and post-antibiotic treatment suggest
that increased abundance of eryR enterococci after administration of tylosin phosphate
reflects selection for strains that were already present within the gastrointestinal tract of
cattle at arrival.
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Introduction
Subtherapeutic administration of antibiotics in livestock feed has
come under increasing scrutiny due to concerns that such a
practice increases the emergence of antibiotic resistant bacteria
(Aarestrup, 1999). This concern is particularly relevant for
bacteria that reside in livestock and are associated with clinical
infections in humans.
Enterococci are commensal bacteria of the human and bovine
gastrointestinal tract, but are also associated with nosocomial
and community-acquired infections in humans (Poh et al., 2006;
Franz et al., 2011). Enterococcus faecalis and Enterococcus faecium
are the two species most frequently associated with enterococcal
infections in humans, being responsible for as much as a third
of the nosocomial infections worldwide (Werner et al., 2008).
Whereas in cattle, Enterococcus hirae, a species not commonly
associated with human infections is predominately isolated from
bovine feces (Anderson et al., 2008; Jackson et al., 2010; Zaheer
et al., 2013).
In North America, tylosin phosphate is commonly included
in cattle feed for the control of liver abscesses (Page and
Gautier, 2012). Previous research has shown therapeutic and
subtherapeutic administrations of macrolides to cattle increases
the proportion of erythromycin resistant enterococci in bovine
feces (Jacob et al., 2008; Zaheer et al., 2013). In 2005, the
WHO identifiedmacrolides as critically important antimicrobials
for which management strategies are urgently required to
reduce the prevalence of bacterial resistance (Collignon et al.,
2009). Macrolides are part of the MLSB (macrolide-lincosamide-
stretogramin B) superfamily with each antibiotic having slight
structural differences, but resistance to one member of the
family can cross-select for resistance to other drugs in the
family. Consequently, if the inclusion of tylosin in feed leads
to tylosin resistant enterococci in cattle it may also select
for enterococci that are resistant to other macrolides such as
erythromycin, an antibiotic important for the treatment of
bacterial infections in humans (Roberts, 2008; Desmolaize et al.,
2011).
Enterococci resistant to macrolides commonly carry the
resistance determinant erm(B), an rRNA methlyase that confers
cross-resistance to MLSB antibiotics, or msrC, a macrolide eﬄux
pump (Portillo et al., 2000). Very little is known about the
nature and resistance characteristics of enterococci isolated from
feedlot cattle. If E. hirae is consistently found as the predominant
species in cattle feces, administering macrolides to cattle may not
pose as a significant risk because this species is not commonly
associated with human infections. Furthermore, antibiotics are
often withdrawn prior to slaughter to reduce the risk of
residues contaminating meat. In this study, we hypothesized that
withdrawal of tylosin prior to slaughter would be an effective
method of reducing the risk of resistant enterococci entering the
food chain.
The objectives of this study were to determine the prevalence
of macrolide resistant enterococci recovered from cattle
continuously fed tylosin phosphate, and following its withdrawal.
The recovered enterococci were characterized through species
identification, antimicrobial susceptibility testing, identification
of resistance determinants and pulsed-field gel electrophoresis
(PFGE) profiling.
Materials and Methods
Experimental Design
The enterococci isolates investigated in this study were a subset of
those archived during a larger study. Full methodological details
have been described previously (Alexander et al., 2008; Sharma
et al., 2008) and are summarized briefly below.
British crossbred steers (150± 20 kg) were randomly assigned
to 10 pens (10 steers per pen) at the Lethbridge Research Centre
feedlot (Lethbridge, Alberta, Canada). Steers were obtained from
a single ranch (Deseret Ranches, Raymond, Alberta, Canada) and
received no antibiotics prior to the beginning of the experiment.
Five pens of cattle each were randomly assigned to one of
two treatments: (i) control, no antibiotics (denoted CON); (ii)
tylosin phosphate (Tylan R©, Elanco Animal Health; treatment
denoted T11) at 11 ppm in the diet. Tylosin was administered
continuously for 197 days, starting on arrival at the feedlot
and was withdrawn from the diet 28 days prior to slaughter
(Figure 1). To avoid cross contamination between diets, tylosin
was mixed with 5 kg of supplement and manually spread over
the surface of the feed during the morning feeding. Steers were
fed once daily to ensure that all feed allotted to each pen was
consumed. Steers in CON and T11 treatments were housed in
opposite sides of the feed alley to ensure that steers in different
treatments did not have direct contact with one another. The
animals involved in this study were cared for according to the
guidelines set out by the Canadian Council on Animal Care
(Canadian Council on Animal Care, 2003).
Steers were fed diets typical of the western Canadian feedlot
industry during a growing and finishing period. For the growing
period, a silage-based diet consisting of 70% barley silage, 25%
barley grain, and 5% supplement on a dry-matter (DM) basis
was fed for the first 80 days (Figure 1). Cattle were transitioned
from the silage-based growing diet to a grain-based finishing diet
(85% barley grain, 10% barley silage, and 5% supplement on a
DM basis) over 21 days and maintained on this diet for a further
124 days until slaughtered. A common watering bowl was shared
between adjacent pens on the same treatment.
Sample Collection and Processing
The study occurred from November 2004 to July 2005.
Rectal fecal samples were collected from each steer upon
arrival at the feedlot and monthly thereafter until slaughter
(Figure 1). Proportion of steers positive for macrolide resistant
enterococci, CFU counts and the proportion of macrolide
resistant enterococci in steers were estimated at all 9 sampling
dates with enterococci isolates from 5 of these dates used
for assessing antimicrobial susceptibility, identifying resistance
determinants and PFGE profiles. The five sampling dates were
selected to include isolates prior to administration of tylosin,
during the growing and finishing feeding periods and post-
withdrawal of tylosin from the diet.
On each sampling date, fecal grab samples were collected and
immediately transported to the lab within 1 h after collection. At
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FIGURE 1 | Schematic representation of experiment timeline
(Figure reproduced from Sharma et al., 2008). Numbers indicate
day of feeding period. Periodic orange rectangles indicate points where
fecal samples were collected from steers. A, B, D, E and I represent
points where isolates were selected for assessing antibiotic
susceptibility, PFGE profiles and identifying resistance determinants.
Grey shaded area represents the period that tylosin was administered
in the diet.
TABLE 1 | Distribution of isolates characterized in this study.
Treatmenta Media used Sampling dayc Total
for selectionb
0 14 84 113 225
CON BEA 24 20 25 25 23 119
BEAE 6 8 17 16 9 58
BEAT 9 9 19 22 19 79
T11 BEA 24 20 25 25 25 122
BEAE 6 8 15 20 14 65
BEAT 8 7 24 25 22 86
Total 77 72 125 133 112 519
aSteers fed no antibiotics (control, CON) or tylosin phosphate (11 ppm; T11); administered
continuously and withdrawn on day 197.
b Isolates were streaked onto bile esculin azide agar (BEA) containing no antibiotics, or
amended with erythromycin (8µg/mL; BEAE ) or with tylosin (32µg/mL; BEAT ).
cSampling days began at day 0 (arrival at feedlot) prior to antibiotic administration and
continued until the end of the feeding trial; sample day 0 and 14 were during the silage-
based diet, day 84 during the transition diet and day 113 and 225 during the grain-based
diet.
the lab, fecal slurries were created by mixing feces (10 g) with
90ml of 1× phosphate-buffered saline in a stomacher bag (Fisher
Scientific, Ottawa, Ontario, Canada) and using a Stomacher
(2min, 230 rpm, room temperature; Seward Ltd., Worthing,
West Sussex, United Kingdom). Slurries were serially diluted 10-
fold and 100µL of the appropriate dilution plated in duplicate
onto Bile-Esculin-Azide (BEA; BD, Franklin Lakes, New Jersey,
USA) agar containing no antibiotics or onto BEA amended with
erythromycin (8µg/mL; BEAE), or tylosin (32µg/mL; BEAT)
to select for enterococci resistant to erythromycin or tylosin.
The breakpoint for erythromycin was based on the Clinical
and Laboratory Standards Institute (CLSI) guidelines whilst an
arbitrary value, based on avoiding plate over growth and the
levels used by Davies and Roberts (1999), was selected for tylosin.
Plates were incubated for 48 h at 37◦C and colonies from BEA,
BEAE, and BEAT were enumerated. Two isolates from control
plates and four isolates from antibiotic selective plates were
streaked onto Trypticase soy agar (TSA; BD), incubated for 24 h,
transferred to 20% glycerol in brain heart infusion broth (BD)
and stored at−80◦C until processed.
Characterization of Enterococci
A total of 1029 presumptive enterococci isolates representing
one isolate from each steer fecal sample were revived on the
same media from which they were initially isolated (BEA, BEAE
or BEAT; BD). Cultures were grown over 36 h at 37◦C and
two colonies were selected and suspended in 75µL of TE
(10mM Tris, 1mM EDTA, pH 8.0). Samples were heat lysed
for 5min using a thermomixer set at 98◦C with shaking at
1000 RPM, followed by centrifugation at 10,000 × g for 5min.
The supernatant containing the genomic DNA was used as
a source of template for all PCR reactions. Simultaneously, a
subset of presumptive enterococci consisting of ∼50% isolates
of each category including treatment type, media type and
sampling day were randomly selected for species identification.
In this manner, 519 presumptive enterococci isolates were
selected (Table 1). All of the 1029 isolates were screened by PCR
with Enterococcus specific groES-EL primers Ent-ES-211-233-F
and Ent-EL-74-95-R (Zaheer et al., 2012) for confirmation as
Enterococcus spp. whereas the 519 selected isolates for species
identification were further processed for sequencing of the groES-
EL PCR product. Occasionally, the sequence results of the groES-
EL PCR product varied from publically available databases. In
order to characterize those Enterococcus spp. isolates correctly,
multilocus sequencing including 16S rRNA, atpA, pheS, and rpoA
genes was used to identify species. Detailed methodology can be
found in the supplementary information (Supplementary Figure
1 and Supplementary Table 1). In cases where an isolate did not
generate the groES-EL PCR product, i.e., was not an Enterococcus
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spp., PCR amplification and sequencing of the 16S rRNA gene
using primers 27F (5′-AGAGTTTGATCMTGGCTCAG-3′) and
1492R (5′-TACGGYTACCTTGTTACGACTT-3′) was conducted
for taxonomic identification.
A subset of 171 isolates representing major species (∼25%
coverage) and all minor species were subject to antimicrobial
susceptibility testing. These selected isolates were subject to
PCR-based identification of resistance determinants and PFGE
profiling.
Antimicrobial Susceptibility Testing
Disk susceptibility tests were conducted on 171 characterized
enterococci isolates according to the CLSI documents M02-
A11 and M100-S24 (Clinical and Laboratory Standards Institute,
2014a,b). The antimicrobials tested, suppliers and resistance
breakpoints applied are listed in Table 2. Reference strains
Staphylococcus aureus ATCC 25923 R© and E. faecalis ATCC
29212 R© were used as quality controls. Resulting zones of
inhibition were read using the BioMic V3 imaging system
(Giles Scientific, Inc., Santa Barbara, CA, USA) and classified as
sensitive or resistant based on CLSI interpretive criteria (Clinical
and Laboratory Standards Institute, 2014b), except for tigecycline
which used EUCAST interpretive criteria (The European
Committee on Antimicrobial Susceptibility Testing, (EUCAST),
2014). Neither EUCAST nor CLSI defined breakpoints exist
for enterococci with tylosin, however the quality control
range of tylosin disks (30µg) has recently been acknowledged
for S. aureus ATCC 25923 R© (Buß et al., 2014). Tylosin
minimum inhibitory concentration (MIC) were established
for a sub-set of isolates containing erm(B) or msrC, both
genes or neither gene according to CLSI documents M100-
S24 and M07-A9, with results reported in the supplementary
information (Supplementary Figure 2). Isolates exhibiting a high
MIC (≥128µg/mL) to tylosin also contained the resistance
determinant erm(B). Therefore, isolates harboring the resistance
determinant erm(B) were given the designation of resistant to
tylosin.
Identification of Resistance Determinants
Of selected isolates, 125 isolates displaying intermediate or
complete resistance to erythromycin were screened for the
presence of macrolide resistance determinants. Isolates were first
screened by PCR for the commonly found macrolide resistance
determinants in enterococci, erm(B) and msrC (Portillo et al.,
2000). For erm(B), PCR primers and reaction conditions were
used as described by Chen et al. (2007). For msrC PCR, the
forward and reverse primers, msrC_F1 (5′-TCGTTTTGTCAT
GAGACAAACAG-3′) and msrC_R1 (5′-AAATTAGTCGGT
TCATCTAACAG-3′), respectively were used. A 20µL PCR
reaction using 2µL of template DNA was prepared with the
following reaction conditions: initial denaturation for 5min at
95◦C, followed by 35 cycles of denaturation for 30 s at 94◦C,
annealing for 30 s at 53◦C, extension for 30 s at 72◦C with a final
extension for 10min at 72◦C. The PCR reaction product (5µL)
was resolved on a 2% agarose gel, and visualized for the presence
of a 191 bp PCR product. An environmental sample, showing
positive amplification formsrC and verified by DNA sequencing,
was used as a positive control.
A subset of 40 isolates containing erm(B) or msrC or both
genes and consisting of all identified species with a variety
of PFGE profiles were further screened for the presence of
other macrolide resistance determinants. These included erm(A),
erm(C), erm(F), and erm(T) with primers and reaction conditions
as described by Chen et al. (2007).
Isolates displaying intermediate or complete resistance to
doxycycline were further screened for the tetracycline resistance
determinants tet(B), tet(C), tet(L), and tet(M). A 20µL PCR
reaction using 2µL of template DNAwas prepared with products
TABLE 2 | Antibiotics, suppliers, disk content and breakpoints used for disk susceptibility testing.
Antibiotic Supplier Disk content Zone diameter (mm) breakpointsd
(µg)
S I R
Ampicillina BD 10 ≥17 – ≤16
Doxycyclinea BD 30 ≥16 13–15 ≤12
Erythromycina BD 15 ≥23 14–22 ≤13
Gentamicina BD 120 ≥10 7–9 6
Levofloxacina BD 5 ≥17 14–16 ≤13
Linezolida BD 30 ≥23 21–22 ≤20
Nitrofurantoina BD 300 ≥17 15–16 ≤14
Quinupristin-dalfopristina BD 4.5/10.5 ≥19 16–18 ≤15
Streptomycina BD 300 ≥10 7–9 6
Tigecycline BD 15 ≥18 – <15
Tylosinb Medox 30 n/a n/a n/a
Vancomycina,c BD 30 ≥17 15–16 ≤14
aM100-S24: Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement (Clinical and Laboratory Standards Institute, 2014b).
bBreakpoint tables for interpretation of MICs and zone diameters. Version 4.0. (The European Committee on Antimicrobial Susceptibility Testing, (EUCAST), 2014).
cVancomycin requires 24 h incubation while for all other antibiotics 16–18 h incubation is sufficient.
dZone diameter value used to indicate susceptible (S), intermediate (I), resistant (R) and not available (n/a).
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FIGURE 2 | Proportion of steers positive for eryR enterococci (Steers
eryR) or tylR enterococci (Steers tylR) and Enterococcus counts (log
CFUg−1) of, total population (CFU), eryR enterococci (CFU eryR) or
tylR enterococci (CFU tylR) for CON (A) or T11 (B) treatments. Arrow
indicates when antibiotics were withdrawn from the diet. An “*” indicates
days for which there was a significant difference between eryR and tylR
Enterococcus counts (P < 0.05). For each treatment (day 0, 14, 84, 113, and
225 n = 50; day 49, 141, 169, and 197 n = 30).
resolved on a 2% agarose gel. For tet(B), primers as described
by Peak et al. (2007) were used with the following reaction
conditions; initial denaturation for 5min at 95◦C, followed by
35 cycles of denaturation for 30 s at 94◦C, annealing for 30 s
at 60◦C, extension for 30 s at 72◦C, and a final extension for
10min at 72◦C. Primers and reaction conditions for tet(C), tet(L),
and tet(M) were as described by Ng et al. (2001). The expected
product size for tet(B), tet(C), tet(L), and tet(M) were 205, 418,
267, and 406 bp, respectively.
For all PCR reactions, the commercially available HotStarTaq
Plus Master Mix Kit (Qiagen Canada, Inc., Mississauga, ON,
Canada) was used according to manufacturer’s instructions.
Plasmids containing the corresponding gene fragments were
used as positive controls (Alexander et al., 2009; Zaheer et al.,
2013).
PFGE
One-hundred and seventy-one isolates were subjected to PFGE
profiling with SmaI restriction enzyme using a modified
procedure of PulseNet USA (Center for Disease Control and
Prevention, 2012). Briefly, bacteria grown overnight on brain-
heart infusion-agar (BHI-agar; BD) were harvested using sterile
swabs and suspended in TE buffer to an OD of 1.85 at 610 nm.
An aliquot (400µL) of cell suspension was transferred to a 1.5mL
microfuge tube containing 20µL of lysozyme (50mg/mL; Sigma-
Aldrich, Co., St Louis, Mo, USA), gently mixed and incubated
at 55◦C for 45min. An equal volume of 1.2% molten SeaKem
Gold agarose (Lornza, Rockland, Maine, USA) in TE buffer
was added and the mixture dispensed in duplicate into re-
useable plug molds (Bio-Rad Laboratories, Hercules, CA, USA)
and allowed to solidify at room temperature. Duplicate plugs
were added to 2mL microfuge tubes containing 1.8mL cell
lysis buffer [50mM Tris; 50mM EDTA; 1% sodium sarcosyl]
and 9µL of Proteinase K (20 mg/mL; Sigma-Aldrich, Co., St
Louis, Mo, USA) and incubated for 2 h at 55◦C with agitation
(300 rpm). Plugs were washed twice in sterile, deionized H2O
(1.8mL) and three times in TE (1.8mL) for 10min each using
a thermomixer set at 50◦C and 300 rpm. Restriction digestion
and electrophoresis conditions were as described by Zaheer
et al. (2013). Gels were photographed using an AlphaImager gel
documentation system (Alpha Innotech Corp., St. Leandro, CA,
USA) and banding patterns analyzed with BioNumerics V6.6
software (Applied Maths Inc., Austin, TX, USA), using Dice
coefficient and the unweighted pair group method (UPGMA).
Optimization and band tolerance were both set at 1%. Salmonella
serotype Braenderup digested with XbaI was included in each
gel as a control reference and for normalization of band
fragments.
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Data and Statistical Analysis
Enumeration data were used to determine the proportion
of steers positive for macrolide resistant enterococci and
the proportion of macrolide resistant Enterococcus in the
total population. For the purposes of enumeration, esculin
hydrolyzing colonies observed on BEA, BEAE, and BEAT plates
were assumed to be enterococci.
Data were analyzed using commercially available statistical
analysis software (SAS Systems for Windows, version 9.3, SAS
Institute Inc, Cary, NC, USA). Prior to analysis, enumeration
data were normalized through a log transformation. When
enumeration data for the antibiotic selective media exceeded
that of the non-selective media for each sampling point, it
was assumed that 100% of the population was resistant to the
respective antibiotic. The MIXED procedure of SAS was used to
assess CFU counts over time and the proportion of macrolide
resistant enterococci in the total population. The CFU counts
over time were analyzed with media type, day and media type
× day in the model as fixed effects while for the proportion
of macrolide resistant enterococci in the total population, day,
treatment and day × treatment interaction were included in the
model as fixed effects. For both analyses, day was included as
a repeated measure. Results were considered significant when
P < 0.05. For most sampling days, 50 samples were collected,
but due to conflicts with other experiments in the feedlot
facility, only 30 samples were collected on day 49, 141, 169,
and 197.
Results
Prevalence of Positive Steers and CFU Counts of
Macrolide Resistant Enterococci
Upon arrival at the feedlot, 28 and 24% (CON and T11,
respectively) of the steers were positive for eryR enterococci,
whilst 44 and 38% (CON and T11, respectively) were positive for
tylR enterococci, even though steers did not previously receive
antibiotics (Figure 2).
For the control group, the counts of tylR enterococci were
higher (P < 0.05) than the counts of eryR enterococci on d
0, 84, 113, 141, 169, 197, and 225 (Figure 2A). Whilst for the
tylosin treatment, the counts of tylR enterococci were higher
(P < 0.05) than the counts of eryR enterococci for d 84, 113,
and 225 (Figure 2B). In general, the counts of eryR enterococci
in the tylosin treatment group and counts of tylR enterococci
FIGURE 3 | Proportion of erythromycin-resistant (A) or
tylosin-resistant (B) fecal enterococci isolates for both
treatments across all sampling days. Arrow indicates when
antibiotics were withdrawn from the diet. Line styles distinguish the
treatment. An “*” indicates days for which there was a significant
difference between treatments (P < 0.05). For each treatment (day
0, 14, 84, 113, and 225 n = 50; day 49, 141, 169, and 197
n = 30).
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in both treatment groups increased over the sampling period as
the cattle were transitioned from a silage-based growing diet to
a grain-based finishing diet (Figure 2). The increased counts of
macrolide resistant enterococci over the experiment were due to
an increase in the proportion of macrolide resistant enterococci
within the total population.
Proportion of Macrolide Resistant Enterococci in
the Total Enterococci Population
No difference (P > 0.05) was observed between control and
tylosin-fed steers on d 0, 14, 49, and 84 for the proportion of
eryR enterococci or d 0, 14, and 49 for the proportion of tylR
enterococci (Figures 3A,B, respectively). On d 113, 141, 169, and
197, the proportion of eryR enterococci was higher (P < 0.001)
for steers fed tylosin compared to controls. The proportion of
tylR enterococci, resistance was higher (P < 0.001) for steers
fed tylosin compared to controls on d 84, 113, 141, 169, and
197. After withdrawal of tylosin on d 197, the proportion of
eryR or tylR enterococci decreased until there was no difference
(P > 0.05) between tylosin-fed and control steers on d 225
(Figures 3A,B, respectively).
Characterization of Enterococci
Of the 1029 isolates analyzed, 95.2% were confirmed as
enterococci by PCR. Of the 519 isolates speciated, 504 were
identified as E. hirae (n = 431), Enterococcus villorum
(n = 32), E. faecium (n = 21), Enterococcus durans (n=7),
Enterococcus casseliflavus (n = 4), Enterococcus mundtii (n =
4), Enterococcus gallinarum (n = 3), E. faecalis (n = 1),
and Enterococcus thailandicus (n = 1). The remaining 15
non-enterococci were identified as Lactobacillus spp. (n = 3),
Aerococcus spp. (n = 9), Streptococcus spp. (n = 2), and
Staphylococcus epidermids (n = 1) as determined by 16S
rRNA sequencing. All the species identified were represented
by the 231 isolates originally recovered from BEA, whereas
only six species (E. hirae, E. villorum, E. faecium, E. durans,
E. casseliflavus, and E. gallinarum) were isolated from BEAE
and BEAT (Figure 4). Variants of the groES-EL sequence for
two isolates of E. faecium and single isolates of E. thailandicus
and E. villorum have been submitted to the NCBI database
(Accession numbers KP993544, KP993545, KP993546, and
KP993547, respectively).The diversity of enterococci tended to
be greater in steers upon arrival than at exit from the feedlot.
A greater diversity of enterococci species were isolated from
non-selective BEA compared with either BEAE or BEAT, with
similar proportions of most species occurring in control and
tylosin-fed steers. E. hirae was the predominant species isolated
from both control and tylosin-fed steers across all sampling dates
(Figure 4).
Antibiotic Susceptibility Testing
A subset (n = 171) of enterococci representing all of
the isolated Enterococcus species were tested for antibiotic
susceptibility (Table 3). Resistance to ampicillin, gentamicin,
linezolid, streptomycin or tigecycline was not detected in any of
the isolates. Vancomycin resistance was also absent in all isolates
except for one which displayed intermediate resistance. One
FIGURE 4 | Species distribution of characterized isolates from (A) BEA
(bile esculin azide agar), (B) BEAE (bile esculin azide agar amended
with erythromycin [8µg/mL]) and (C) BEAT (bile esculin azide agar
amended with tylosin [32µg/mL]). Prevalence was calculated by dividing
the number of isolates for each species by the total number of isolates from
each sample day and treatment.
isolate of E. casseliflavus exhibited ERY-TYL-Q-D-van resistance
and one isolate of E. durans exhibited ERY-TYL-q-d (lower
case denotes intermediate resistance and upper case complete
resistance). One isolate of E. faecium was ERY-DOX-TYL-q-
d resistant, with other single isolates exhibiting intermediate
ery-nit, ery-lvx or dox-nit-lvx-q-d resistance. Two isolates of E.
gallinarum showed ery-TYL resistance and a number of E. hirae
isolates were resistant to ERY-TYL (n = 27), ery-TYL (n = 27),
ERY-dox-TYL (n = 8), or ERY-TYL-q-d (n = 7). With one
exception, all E. villorum isolates exhibited ERY-TYL (n = 31)
resistance.
In general, isolates grown on BEAT also exhibited
erythromycin resistance. An exception to this was three isolates
of E. durans isolated on BEAT, which remained susceptible to
erythromycin.
Identification of Resistance Determinants
Of the 125 enterococci isolates displaying intermediate or
complete resistance to erythromycin, the erm(B) gene was
detected in 106 isolates representing E. hirae, E. durans, E.
faecium, E. villorum, E. gallinarum, and E. casseliflavus. Of the
19 erythromycin-resistant E. faecium isolates obtained all except
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TABLE 3 | Number of enterococci isolates (percentage of total speciesa) showing intermediate or complete resistance to antibiotics pooled across
treatments, isolation media and sample date.
Enterococcus spp. Antibioticb (No. isolates [%])
AMP DOX ERY GEN LVX LZD NIT Q-D STR TGC TYLc VAN
E. hirae (n = 98) I n/a 8 (8.2) 27 (27.6) 0 0 0 0 7 (7.1) 0 n/a n/a 0
R 0 0 42 (42.9) 0 0 0 0 0 0 0 69 (70.4) 0
E. villorum(n = 32) I n/a 0 0 0 0 0 0 0 0 n/a n/a 0
R 0 0 31 (96.9) 0 0 0 0 0 0 0 31 (96.9) 0
E. faecium (n = 21) I n/a 1 (4.8) 5 (23.8) 0 2 (9.5) 0 2 (9.5) 2 (9.5) 0 n/a n/a 0
R 0 1 (4.8) 14 (66.7) 0 0 0 0 0 0 0 1 (4.8) 0
E. durans (n = 7) I n/a 0 0 0 0 0 0 1 (14.3) 0 n/a n/a 0
R 0 0 1 (14.3) 0 0 0 0 0 0 0 1 (14.3) 0
E. casseliflavus (n = 4) I n/a 0 0 0 0 0 0 0 0 n/a n/a 1 (25.0)
R 0 0 2 (50.0) 0 0 0 0 1 (25.0) 0 0 2 (50.0) 0
E. mundtii (n = 4) I n/a 0 0 0 0 0 0 0 0 n/a n/a 0
R 0 0 0 0 0 0 0 0 0 0 0 0
E. gallinarum (n = 3) I n/a 0 2 (66.7) 0 0 0 0 0 0 n/a n/a 0
R 0 0 0 0 0 0 0 0 0 0 2 (66.7) 0
E. faecalis (n = 1) I n/a 0 0 0 0 0 0 0 0 n/a n/a 0
R 0 0 0 0 0 0 0 1 (100.0) 0 0 0 0
E. thailandicus (n = 1) I n/a 0 1 (100.0) 0 0 0 0 0 0 n/a n/a 0
R 0 0 0 0 0 0 0 0 0 0 0 0
aPercentages were calculated by dividing resistant isolates with the total number of isolates for individual species and rounded to the first decimal place.
bAMP, ampicillin; DOX, doxycycline; ERY, erythromycin; GEN, gentamicin; LVX, levofloxacin; LZD, linezolid; NIT, nitrofurantoin; Q-D, quinupristin-dalfopristin; STR, streptomycin; TGC,
tigecycline; TYL, tylosin; VAN, vancomycin.
cResistance isolates were classified as those which carried the erm(B) resistance gene (see Section Materials and Methods for more information).
R, complete resistance; I, intermediate resistance; n/a, no interpretive criteria for intermediate resistance.
one lacked erm(B), but all were positive for msrC. The isolate
identified as E. thailandicus displayed intermediate resistance to
erythromycin, but was negative for all of the macrolide resistance
determinants tested. None of the isolates tested positive for the
other macrolide resistance determinants.
A total of 10 isolates displayed intermediate or complete
resistance to doxycycline. None of the isolates were positive for
tet(B) or tet(C). All 10 isolates were positive for tet(M) and 9 were
positive for tet(L).
PFGE
The PFGE profiles of E. faecium, E. villorum and erythromycin
resistant E. hirae are displayed in Figures 5–7, respectively. E.
faecium had at least 16 isolates from different steers with the same
PFGE profile, suggesting the presence of a clonal population.
Isolates from this clonal population were isolated only on day 0
(Figure 5). The similarity (>95%) of PFGE profiles of E. villorum
also suggested clonality (Figure 6). Unlike E. faecium, these
profiles appeared on day 14 of the trial and persisted until the
end of the experiment. PFGE profiles of erythromycin resistant
E. hirae produced 8 clusters with>85% similarity (Figure 7).
Discussion
Enterococci are ubiquitous in nature and are frequently isolated
from the gastrointestinal tract of mammals, including humans
(Franz et al., 2011). Of the enterococci recovered from this study
E. hirae was revealed to be the predominant species isolated, an
observation consistent with previous studies (Anderson et al.,
2008; Jackson et al., 2010; Zaheer et al., 2013).
Enterococci have been described as a “drug resistance gene
trafficker” due to the ease with which they can acquire and
transfer resistance genes (Werner et al., 2013). They have
emerged as a serious threat to human health, particularly due
to the acquisition of vancomycin resistance, increasing the
difficulty of successful treatment (Center for Disease Control and
Prevention, 2013). Of the 171 isolates examined for antibiotic
resistance, only one isolate displayed intermediate resistance
to vancomycin. This isolate was identified as E. cassiflavus,
an outcome that likely reflects the intrinsic resistance of E.
casseliflavus and E. gallinarum to low levels of vancomycin
(Hollenbeck and Rice, 2012). This observation is encouraging,
as the enterococci isolated from beef cattle do not appear to
represent a significant source of vancomycin resistance.
E. faecium and E. faecalis are the two species most commonly
associated with nosocomial human infections (Ruoff et al., 1990;
Werner et al., 2008; Sievert et al., 2013). These species have
been isolated from cattle (Kuhn et al., 2003; Anderson et al.,
2008; Jackson et al., 2010), but they do not predominate, with
our study suggesting that their prevalence declines after cattle
enter the feedlot. Although E. hirae, as well as other enterococcal
species (i.e., Enterococcus avium, E. durans, E. casseliflavus,
E. gallinarum, and Enterococcus raffinosus) can cause clinical
infections in humans, they are rare and thought to be more
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FIGURE 5 | Dendrogram of PFGE SmaI profiles from isolates
identified as Enterococcus faecium. A “+” indicates PCR positive and
“−” indicates PCR negative to the respective genes. A “blank” space
indicates the gene was not screened for in the respective isolate. For the
antibiogram, upper case denotes complete resistance and lower case
denotes incomplete resistance.
opportunistic in nature than those caused by E. faecium and E.
faecalis (Ruoff et al., 1990; Alfouzan et al., 2014). Presence of E.
hirae predominantly in the bovine gastrointestinal tract suggests
that cattle do not present a significant source of Enterococcus that
could colonize and infect humans.
In the absence of selection, the predominant resistance
phenotype observed in the enterococci recovered from cattle
was to erythromycin or tylosin, including isolates recovered pre-
and post- antibiotic treatment. Despite no prior treatment with
antimicrobials, steers harbored eryR (28 and 24%, CON and T11
respectively) and tylR (44 and 38%, CON and T11 respectively)
enterococci upon arrival at the feedlot (Figure 2). This suggests
that naturally occurring resistance determinants coding for
macrolide resistance are already present and circulating in bovine
gut enterococci populations.
For some days, the counts of tylR enterococci were higher
(P < 0.05) than eryR enterococci for both treatment groups
(Figure 2). It would be expected that similar counts would be
obtained for both eryR and tylR enterococci as the same resistance
mechanism confers resistance to both antibiotics (Roberts, 2008;
Desmolaize et al., 2011). Enterococci with both intermediate
and complete resistance to erythromycin were isolated from
tylosin plates; erythromycin plates only selected for enterococci
with complete resistance to erythromycin, explaining some of
the discrepancy seen between enumeration data for the two
media. Isolates from tylosin media with intermediate resistance
to erythromycin also carried the erm(B) gene. It appears that the
MIC breakpoint for erythromycin may be too high, therefore
missing enterococci with intermediate resistance which also
carry a resistance determinant. Conversely, the MIC breakpoint
for tylosin may be too low thereby selecting for isolates that
contain resistance determinants that may be compromised,
resulting in an intermediate resistance phenotype. The fact that
three isolates of E. durans from the tylosin media remained
susceptible to erythromycin supports this theory. It is possible
however, that these isolates carry a resistance determinant not
screened for. It would be worthwhile to further explore the likely
genetic differences between the resistance determinant(s) from
complete and intermediate tylosin resistant isolates to identify
the linkage between antimicrobial resistance (AMR) genotype
and phenotype.
As the trial progressed, the number of steers positive for
macrolide resistant enterococci increased in both treatment
groups. This increase, even in the control group may be a
reflection of increased transmission between steers due to close
proximity in the feedlot environment. Likewise, the changing
population dynamics of enterococci in the gastrointestinal tract
of cattle may also contribute to increased transmission. Increased
shedding of macrolide resistant enterococci would increase
the likelihood of cattle being exposed to macrolide resistant
enterococci and thus also increase the detection of positive cattle.
Similarly, an increase in the proportion of the population that
are macrolide resistant would increase the chances of isolating
macrolide resistant enterococci. For a steer to be considered
positive in this study, isolation of a single macrolide resistant
enterococci colony was required. In order to make an assessment
of resistance development it is important to look at resistance as
a proportion of the total enterococci population.
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FIGURE 6 | Dendrogram of PFGE SmaI profiles from isolates
identified as Enterococcus villorum. A “+” indicates PCR positive and
“−” indicates PCR negative to the respective genes. A “blank” space
indicates the gene was not screened for in the respective isolate. For the
antibiogram, upper case denotes complete resistance and lower case
denotes incomplete resistance.
The CFU counts of the overall enterococci population
remained relatively constant over the experiment for both
treatments (Figure 2). This trend was also true for CFU counts
of eryR enterococci in the control group (Figure 2A), whilst the
CFU counts of eryR enterococci in the tylosin treatment group
tended to increase during the period of tylosin administration
before dropping off on d 197, presumably due to its withdrawal
from the diet (Figure 2B). This trend was also observed for the
CFU counts of tylR enterococci for both treatments, with possible
differences between eryR and tylR CFU being attributed to the
selection of intermediate resistant enterococci on the tylosin
media (Figure 2). A delay between the increase of CFU counts
and tylosin administration can be seen, with increases coinciding
with the transition from a silage-based diet to a grain-based diet.
High-grain diets tend to increase the amount of starch
available in the lower intestinal tract, changing the nutrient
availability for bacterial growth (Callaway et al., 2009). Previous
researchers have reported a 1 (Scott et al., 2000) to 3 log (Diez-
Gonzalez et al., 1998) increase in Escherichia coli when cattle
were transitioned from a forage- to a grain-based diet. Changes
that occur in the gastrointestinal environment of cattle as a
result of increased starch in the diet alter the composition of the
microbiome (Shanks et al., 2011). It is possible that the transition
to a grain-based diet created conditions ideal for proliferation of
macrolide resistant enterococci. Although not seen with the CFU
of eryR enterococci, the increase of tylR enterococci in both the
control and tylosin treatment group, suggest factors other than
administration of tylosin may have been selecting for macrolide
resistant enterococci.
Increases in eryR enterococci in cattle as a result of the
administration of tylosin has been previously documented (Jacob
et al., 2008; Zaheer et al., 2013), but these authors did not
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FIGURE 7 | Dendrogram of PFGE SmaI profiles from isolates
identified as erythromycin resistant Enterococcus hirae. A “+”
indicates PCR positive and “−”indicates PCR negative to the respective
genes. A “blank” space indicates the gene was not screened for in the
respective isolate. For the antibiogram, upper case denotes complete
resistance and lower case denotes incomplete resistance.
study the effect of withdrawal of tylosin from the diet. As in
previous studies, there was an increase in the proportion of eryR
and tylR resistant enterococci isolated from cattle administered
tylosin. The proportion of eryR and tylR resistant enterococci
for the tylosin treatment began decreasing just prior to removal
of tylosin from the diet and continued to decrease after its
withdrawal, until no difference (P > 0.05) was observed between
treatments on d 225 (Figure 3). It appears that withdrawal of
tylosin phosphate prior to slaughter contributes to a reduction
in the proportion of macrolide resistant enterococci entering
the food chain. However, the possibility that other unknown
factors such as stress, age and diet may also be influencing
this decline cannot be eliminated. It would be interesting to
investigate this phenomenon further to determine why this
reduction is occurring prior to the withdrawal of tylosin from
the diet.
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A decrease in Enterococcus species diversity was observed
as the experiment progressed, with E. hirae being the
predominant species identified. Transitioning of the
diet from a forage- to a grain-based diet alters the fecal
microbiome of cattle (Shanks et al., 2011). Diet may be a
contributing factor in the shift in species diversity seen in
this study, but it is also possible that other factors, such
as age, may be influencing the fecal microbial community
(Devriese et al., 1992).
In this study, E. thaliandicus and E. villorum were identified
using multilocus sequencing of 16S rRNA, atpA, pheS, and
rpoA genes after the discovery of groES-EL PCR products
that varied from publically available databases (Supplementary
Figure 1). To our knowledge, these species have not been
previously isolated from cattle. E. thailandicus was first isolated
in 2008 from fermented sausage in Thailand (Tanasupawat
et al., 2008) and has been found in swine feces (Liu
et al., 2013). E. villorum was first isolated in 2001 from
piglets (Vancanneyt et al., 2001). Traditional methods of
identifying Enterococcus species rely on biochemical tests
which are unreliable for atypical species or species that have
not been previously isolated (Deasy et al., 2000; Jackson
et al., 2004). Molecular techniques have the advantage of
being able to differentiate between closely related enterococci
species.
Erythromycin resistant enterococci possessed either
erm(B) or msrC or both resistance genes. Isolates
designated as tylosin resistant possessed erm(B). Other
macrolide resistance determinants were absent in the
subset of isolates screened and it is possible that isolates
not screened may have contained macrolide resistance
determinants other than erm(B) or msrC. Presence of at
least one resistance determinant in these isolates however
confirmed the association between resistance phenotype and
genotype.
Eight isolates of E. hirae and one isolate of E. faecium displayed
complete resistance to erythromycin and either complete or
intermediate resistance to doxycycline. These isolates were all
positive for erm(B), tet(L), and tet(M). The resistance genes
erm(B) and tet(M) are often associated with the transposon
Tn1545 (Clewell et al., 1995; Rice, 1998). The transposon
integrase gene (int gene) of Tn916/Tn1545 family of transposons
has been previously detected in enterococci (De Leener et al.,
2004). The identification of erm(B) and tet(M) in the same
isolate in this study could possibly suggest the presence of mobile
genetic elements. It would be worthwhile to investigate this
further as many erm genes are often linked with other antibiotic
resistance genes, tetracycline in particular (Roberts et al., 1999).
Linkage of macrolide and other resistance genes is potentially
problematic as administrating tylosin to cattle may not only select
for macrolide resistance, but also for resistance to antibiotics such
as tetracycline. Co-selection of tetracycline resistance upon the
administration of tylosin has been suggested to occur within the
fecal microbial communities of beef cattle (Chen et al., 2008).
Linkage of these genes on mobile genetic elements increases
the potential for the transfer of genes conferring resistance
to multiple antibiotics (Hegstad et al., 2010; Tremblay et al.,
2012).
Pulsed-field gel electrophoresis revealed a predominate cluster
of E. faecium containing msrC and displaying a similar AMR
profile of intermediate or complete resistance to erythromycin.
Sequencing of msrC revealed that all isolates within this
cluster had identical sequences. However, there were sequence
differences in the msrC gene among these isolates and isolates
with unique PFGE profiles (Figure 5). The four newly identified
sequences have been submitted to the NCBI sequence database
(Accession numbers KP775623, KP775624, KP775625, and
KP775626).
Similar PFGE profiles were seen pre- and post-antibiotic
treatment for erythromycin resistant E. hirae, highlighting that
administration of tylosin selected for erythromycin resistant
enterococci already present in the bovine gastrointestinal tract.
These same profiles were still present after d 225; 28 days after
tylosin had been removed from the diet. This suggests that
although administration of tylosin increased the proportion of
macrolide resistant enterococci in beef cattle it does not appear
to be promoting the transfer of resistance between isolates. Once
the selection pressure is removed (withdrawal of tylosin), the
proportion of macrolide resistant enterococci returned to levels
seen before antibiotic treatment.
Conclusion
Few studies have investigated the role that administration of
tylosin in the feed of beef cattle has on the development of
macrolide resistance in enterococci. This study demonstrated
that administering tylosin to cattle increases the proportion of
macrolide resistant enterococci. Withdrawal of tylosin from the
diet appears to contribute to the decline in macrolide resistant
enterococci but may not be the only factor influencing this
decline. Furthermore, transitioning cattle to a grain based diet
appears to alter the species population of enterococci to one
in favor of E. hirae, a species not commonly associated with
infection in humans. PFGE profiling of erythromycin resistant
E. hirae suggest that antibiotic administration selects resistant
strains already present in the intestinal microbial population.
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